Armstrong Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Buy |
8,920
+2,895
| +48% | +$70.2K | 0.02% | 198 |
|
|
2025
Q1 | $160K | Hold |
6,025
| – | – | 0.01% | 214 |
|
|
2024
Q4 | $160K | Buy |
6,025
+152
| +3% | +$4.03K | 0.01% | 214 |
|
|
2024
Q3 | $170K | Sell |
5,873
-1,052
| -15% | -$30.4K | 0.01% | 205 |
|
|
2024
Q2 | $194K | Buy |
6,925
+480
| +7% | +$13.4K | 0.02% | 186 |
|
|
2024
Q1 | $186K | Hold |
6,445
| – | – | 0.02% | 187 |
|
|
2023
Q4 | $186K | Sell |
6,445
-1,190
| -16% | -$34.3K | 0.02% | 187 |
|
|
2023
Q3 | $253K | Buy |
7,635
+463
| +6% | +$15.4K | 0.03% | 145 |
|
|
2023
Q2 | $263K | Sell |
7,172
-1,075
| -13% | -$39.4K | 0.03% | 144 |
|
|
2023
Q1 | $336K | Sell |
8,247
-508
| -6% | -$20.7K | 0.04% | 115 |
|
|
2022
Q4 | $449K | Buy |
+8,755
| New | +$449K | 0.06% | 94 |
|